Recombinant Citrobacter koseri Cardiolipin synthase (cls)

Shipped with Ice Packs
In Stock

Description

Functional Role of Cardiolipin Synthase

Cardiolipin synthase (cls) enzymes catalyze the final step in CL biosynthesis, which varies across organisms:

  • Bacterial Mechanism:

    • Type I: Transfers a phosphatidyl group from phosphatidylglycerol (PG) to another PG, producing CL and glycerol.

    • Type II: Utilizes CDP-diacylglycerol (CDP-DAG) as the phosphatidyl donor, forming CL and CMP (eukaryotic-like mechanism) .

Citrobacter koseri cls likely follows the bacterial Type I mechanism, as inferred from its classification in the phospholipase D superfamily .

Role in Membrane Stability and Bacterial Pathogenesis

CL is essential for maintaining membrane curvature, proton gradient stability, and virulence in pathogens. For example:

  • In Staphylococcus aureus, CL depletion via cls1 and cls2 deletion reduces cytotoxicity to neutrophils and virulence in mouse models .

  • In E. coli, CL synthesis is regulated by osmolarity and growth phase, with three distinct cls genes (clsA, clsB, clsC) ensuring redundancy .

Comparative Analysis of CLS Enzymes

OrganismCLS TypeSubstratesKey Function
E. coliType I (clsA/B)PG + PG → CL + glycerolPrimary CL synthesis in log phase
StreptomycesType IICDP-DAG + PG → CL + CMPEukaryotic-like CL synthesis
C. koseriType I (inferred)PG + PG → CL + glycerolMembrane stability, virulence

Experimental Insights from Recombinant CLS

The recombinant C. koseri cls protein is used in:

  • ELISA Assays: Detection of anti-cls antibodies in research or diagnostic settings .

  • Biochemical Studies: Characterization of CLS activity, substrate specificity, and inhibition kinetics.

  • Structural Biology: Crystallization and X-ray diffraction studies to elucidate active-site architecture.

Challenges and Future Directions

  • Mechanistic Gaps: The precise catalytic mechanism of C. koseri cls remains uncharacterized, necessitating in vitro assays to confirm substrate preferences.

  • Pathogenicity Links: Investigating whether CLS inhibition impacts C. koseri virulence, as seen in S. aureus .

  • Therapeutic Potential: Exploring CLS as a drug target for antimicrobial development, given CL’s role in bacterial membrane integrity.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a reference for your use.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during the production process. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
clsA; cls; CKO_01326; Cardiolipin synthase A; CL synthase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-486
Protein Length
full length protein
Species
Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696)
Target Names
clsA
Target Protein Sequence
MTTFYTVVSWLVILGYWILIAGVTLRILMKRRAVPSAMAWLLIIYILPLVGIIAYLSFGE LHLGKRRAERARAMWPSTAKWLNDLKACKHIFAEENSSVASSLFKLCERRQGIAGVKGNQ LQLLTDSDDVMQALIRDIQLARHNIEMVFYIWQPGGMADQVAESLMAAARRGIHCRLMLD SAGSVAFFRSPWAAMMRNAGIEVVEALKVNLMRVFLRRMDLRQHRKMVMIDNYIAYTGSM NMVDPRFFKQDAGVGQWVDLMARMEGPVATAMGIVYSCDWEIETGKRILPPPPDVNIMPF EQASGHTIHTIASGPGFPEDLIHQALLTAAYSAREYLIMTTPYFVPSDDLLHAICTAAQR GVDVSIILPRKNDSMLVGWASRAFFTELLAAGVKIYQFEGGLLHTKSVLVDGELSLVGTV NLDMRSLWLNFEITLVIDDAGFGGDLAAVQDDYISRSRLLDARLWVKRPLWQRITERLFY FFSPLL
Uniprot No.

Target Background

Function
Catalyzes the reversible transfer of phosphatidyl groups between phosphatidylglycerol molecules to form cardiolipin (CL) (diphosphatidylglycerol) and glycerol.
Database Links
Protein Families
Phospholipase D family, Cardiolipin synthase subfamily, ClsA sub-subfamily
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.